CD20-bispecific antibodies improve response to CD19-CAR T-cells in lymphoma in-vitro and CLL in-vivo models.
Brinkmann BJ, Floerchinger A, Schniederjohann C, Roider T, Coelho M, Mack N, Bruch PM, Liebers N, Dötsch S, Busch DH, Schmitt M, Neumann F, Roessner PM, Seiffert M, Dietrich S.
Brinkmann BJ, et al. Among authors: coelho m.
Blood. 2024 May 28:blood.2023022682. doi: 10.1182/blood.2023022682. Online ahead of print.
Blood. 2024.
PMID: 38805637